| The distinguished scientists who comprise the External Advisory Board meet annually to evaluate JHMRI policy and provide guidance in setting priorities and procedures. Board members also serve on the JHMRI Pilot Grant Review Committee. - Donald D. Brown, MD, is the Director of the Department of Embryology at Carnegie Institution of Washington in Baltimore, Maryland. His research interest is Amphibian Metamorphosis. In February, 2009 Dr. Brown received the Lifetime Achievement Award from the Society for Developmental Biology.
- Paul T. Englund, PhD, is a professor of biological chemistry at the Johns Hopkins University School of Medicine. Focusing on the biochemistry and molecular biology of parasitic protozoa, he investigates the biology of trypanosomes, the protozoan parasites responsible for important tropical diseases.
Daniel E. Goldberg, MD, PhD, is a professor in the departments of Medicine and Molecular Microbiology at Washington University and an investigator of the Howard Hughes Medical Institute. He is director of the Medical Scientist Training Program and co-chief of the Infectious Diseases Division. Dr. Goldberg studies the biochemistry of Plasmodium falciparum, focusing on proteolytic events responsible for hemoglobin degradation and host cell exit.
Frank L. Hurley, PhD, is chairman and chief scientific officer for RRD International, Inc., a biotechnology product development company. Dr. Hurley has been involved in more than 200 successful clinical studies of pharmaceuticals, biologics, medical devices and diagnostic products, as well as a number of epidemiologic studies of the long-term effects of drugs and medical devices. He co-founded the Biometric Research Institute in 1971, serving as chairman and chief scientific officer until its 1996 merger with Quintiles Transnational Corporation.
Thomas Kelly, MD, PhD, is director of the Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center. Previously, he was the Boury Professor and chairman of the Department of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine. In 2000, he was named founding director of the University's Institute for Basic Biomedical Sciences. Dr. Kelly's work has focused for many years on how the genome is duplicated during the cell cycle, particularly the ways in which replication of DNA is initiated and controlled.
Gregory Lanzaro, PhD, is director of the University of California Mosquito Research Program, UC Davis, which coordinates related research at all UC campuses and administers a competitive grants program. Prior to this, he was professor at the Center for Tropical Diseases, University of Texas Medical Branch, and a MacArthur Fellow at the Laboratory of Malaria Research at the National Institutes of Health. His research interest is in the area of insect vector genetics, with a focus on the population genetics of malaria vectors in Africa. He also focuses on evolutionary interactions among vector, parasites and mammalian host at the molecular level, based on analysis of insect salivary proteins and the genes that encode them.
- Bernard Roizman, ScD, is Joseph Regenstein Distinguished Service Professor of Virology in the departments of Molecular Genetics and Cell Biology and of Biochemistry and Molecular Biology at the University of Chicago. A member of the National Academy of Sciences and American Academy of Arts and Sciences, Dr. Roizman received the first ICN International Prize in Virology, the largest prize in the field, for his pioneering work on herpes viruses. He is also one of the founding scientists at Aviron (a biopharmaceutical firm focusing on disease prevention), which was recently acquired by MedImmune.
- Alfred Sommer, MD, MHS, is Professor and Dean Emeritus, in the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health. He was Dean of the Johns Hopkins Bloomberg School of Public Health from 1990-2005. His research interests include outcome assessments, child survival, epidemiology of visual disorders, glaucoma, vitamin A deficiency, blindness prevention strategies, cost-benefit analysis, the growing interface between medicine and public health and clinical guidelines.
|
